Mylanta

Quick links to important sections

Mylanta

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mylanta

What is Mylanta?

Mylanta is a brand name for a line of over-the-counter medications used primarily to manage symptoms related to excess stomach acid. It is classified as an antacid and antigas medication. The formulation typically consists of a combination of active ingredients that work through different mechanisms to provide relief from gastrointestinal discomfort.

Composition

While specific formulations may vary, the most common active ingredients found in Mylanta products include:

  • Aluminum Hydroxide: An inorganic salt that reacts with excess hydrochloric acid in the stomach.
  • Magnesium Hydroxide: Often referred to as milk of magnesia, this compound also serves as an antacid.
  • Simethicone: An anti-foaming agent used to reduce bloating and discomfort caused by excess gas.

Mechanism of Action

Mylanta works through two primary pathways:

  1. Acid Neutralization: The aluminum and magnesium components act as weak bases. When ingested, they react chemically with the gastric acid produced by the stomach lining, increasing the pH level. This process helps to reduce the acidity of the stomach contents, which can alleviate the burning sensation associated with acid reflux and indigestion.
  2. Gas Reduction: Simethicone works by changing the surface tension of gas bubbles in the stomach and intestines. This causes smaller bubbles to coalesce into larger ones, making it easier for the body to expel gas naturally, thereby relieving pressure and bloating.

General Uses

Mylanta is commonly used to address symptoms such as:

  • Heartburn
  • Acid indigestion
  • Sour stomach
  • Pressure and bloating caused by gas

By neutralizing acid and facilitating the movement of gas, the medication aims to provide temporary relief from the physical discomfort associated with these common digestive issues.

What side effects are possible with Mylanta?

Possible Side Effects and Safety Information

The safety profile of Mylanta is officially documented based on its active ingredients: aluminum hydroxide, magnesium hydroxide, and simethicone. The majority of observed adverse reactions are categorized under Gastrointestinal Disorders and are considered common.


Adverse Reaction Scope

The most commonly listed adverse effects are related to the individual antacid components. Constipation is associated with the aluminum component, while diarrhea is linked to the magnesium component. Fecal discoloration has also been officially noted. Due to the combination of these ingredients, these effects may be counterbalanced, though individual susceptibility varies.

Adverse Reaction Category Official Examples System-Organ Class Frequency
Common Effects Constipation, Diarrhea Gastrointestinal Disorders Common

Systemic Risk and Population-Specific Safety

The most serious adverse reactions are associated with the accumulation of the mineral ions, typically linked to prolonged use or high-dose exposure. These effects fall under Metabolism and Nutrition Disorders and Renal and Urinary Disorders.

  • Serious Adverse Reactions: Officially documented systemic risks include Hypophosphatemia (low phosphate levels) and accumulation issues such as Aluminum intoxication and severe Hypermagnesemia (excess magnesium).
  • Population-Specific Constraints: Regulatory labeling notes that patients with severe renal impairment are at a heightened risk for ion accumulation due to impaired excretion. Older adults may also be more susceptible to the constipating effects, and individuals on a low-phosphate diet are prone to Hypophosphatemia.

Safety-Related Restrictions

Official regulatory documents state that the medication is generally restricted for use in cases of severe abdominal pain or suspected bowel obstruction. Furthermore, antacids may interfere with the absorption of other orally administered medicines by altering the stomach's pH, a general safety characteristic noted in the overall risk profile.

Overdose and Emergency Response

The official regulatory guidance for Mylanta (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) defines overdose risk based on immediate gastrointestinal effects and the potential for severe systemic toxicity. Acute ingestion in excess of the labeled dose may present with common gastrointestinal issues, specifically diarrhea or constipation.


Emergency Action Required

In the event of accidental overdose, regulatory labeling explicitly mandates users to get medical help or contact a Poison Control Center right away. Immediate medical attention is required due to the documented potential for severe systemic outcomes.


Systemic Toxicity and Risk Factors

The most serious risks are associated with high-dose or chronic excessive exposure, leading to the accumulation of active ingredients. This can result in increased blood levels of magnesium ( Hypermagnesemia), which may cause symptoms like confusion, drowsiness, muscle weakness, and cardiac effects. In rare instances, aluminum intoxication is a documented risk, associated with neurological and skeletal complications. Patients with kidney disease are explicitly noted to be at a heightened risk for this accumulation and subsequent severe toxicity. Management for mild overdoses typically involves the discontinuation of the drug.

Therapeutic Uses of Mylanta

Mylanta is commonly used to help with acute or disruptive symptom patterns related to upper gastrointestinal distress. The combination of active ingredients is relevant for easing symptom clusters that interfere with daily comfort, and is relevant for easing symptoms related to inflammatory or irritative states and symptoms of increased neurological or muscular activity.

Mylanta is applied in addressing symptom clusters that create noticeable physiological strain. The medication may assist with easing symptoms related to physical discomfort, specifically including heartburn, acid indigestion, sour stomach, pressure, and bloating commonly associated with gas. It is commonly used across conditions presenting with acute episodes.

Overall, this medication contributes to improved comfort during periods of heightened symptoms. It is relevant when supportive symptom management is appropriate for temporary physiological imbalance, and is often used when relief is needed for an upset stomach due to overindulgence in food and drink. One patient-oriented benefit is that the product supports the patient during difficult episodes by easing distress.

Quick Fact: Relief for Heartburn and Gas

Regulatory References

  1. NIH DailyMed official drug label

Eligibility and Restrictions for Use

The official regulatory profile for Mylanta defines eligibility based on a clear age threshold and specific health conditions. Adults and adolescents 12 years and older are approved for standard, over-the-counter use. Use in children under 12 years is not established and requires consultation with a doctor.

Contraindicated Populations

The medicine is contraindicated and must not be used in specific high-risk populations, including patients with known hypersensitivity to any component, or those with kidney failure (renal failure), or hypophosphatemia (low blood phosphate levels).

Conditional Use Restrictions

Conditional use is required, mandating that the user "Ask a doctor before use", for the following groups, as per official labeling:

  • Renal Function: Patients with kidney disease or those on a magnesium-restricted diet, due to the potential for active ingredient accumulation. Prolonged use is generally not recommended for those with renal impairment.
  • Physiological Status: Individuals who are pregnant or breast-feeding.
  • Concurrent Therapy: Patients who are presently taking a prescription drug, as antacids may affect their absorption.

This structure adheres to the regulatory focus on population constraints, defining which groups are prohibited from use and which require medical supervision.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Mylanta, containing Aluminum Hydroxide and Magnesium Hydroxide, primarily engages in pharmacokinetic interactions that alter the absorption and systemic exposure of other oral medications. These interactions are officially documented to affect the way numerous drugs are taken up by the body.

Documented Interaction Patterns

The most significant interaction involves a reduced plasma concentration and exposure (AUC/Cmax) for many co-administered oral medicines. This effect occurs because the antacids bind to certain drugs or raise the pH level within the stomach, which is necessary for the proper dissolution and absorption of those medicines. Affected drug classes include Quinolone Antibiotics (e.g., Ciprofloxacin), Tetracycline Antibiotics (e.g., Doxycycline), Iron Salts, and Thyroid Products (e.g., Levothyroxine).

To mitigate the risk of therapeutic failure due to reduced exposure, regulatory information mandates a timing separation between the administration of the antacid and the susceptible prescription medicine. This separation is typically specified as at least two hours.

Interaction Type Specific Effect Documented
Drug–Substance Co-administration with Citrates is documented to significantly increase the absorption and concentration of Aluminum in the body, which is a particular concern for patients with renal dysfunction.
Pharmacodynamic Systemic absorption of the Aluminum and Magnesium ions can alter the pH of the urine, which affects the renal clearance of other drugs, such as Salicylates (increased clearance) and Quinidine (decreased clearance).

The official interaction profile does not list any CYP-enzyme or drug transporter-mediated interactions for this product.

Mechanism of Action

The mechanism of Mylanta involves a rapid, localized physical and chemical intervention within the gastrointestinal tract, targeting acid, enzymes, and trapped gas.

Direct Chemical Neutralization of Gastric pH

This domain involves the active ingredients, Aluminum Hydroxide and Magnesium Hydroxide, acting as alkaline bases to directly react with and consume Hydrochloric Acid ( HCl) in the stomach. The immediate chemical neutralization rapidly increases the gastric pH. This molecular action rapidly reduces the chemical irritation of the mucosal lining, diminishing the stimulus that activates afferent nociceptive signaling. This rise in pH also causes a rapid, reversible inactivation of the enzyme Pepsin, which diminishes the enzyme's proteolytic activity.

️ Physical Modulation of Gas Surface Dynamics

This distinct mechanistic domain is mediated by Simethicone, which does not engage in chemical reactions or receptor binding. Instead, it acts as a polymeric surfactant to lower the surface tension of the gastrointestinal contents. This physical change causes small, dispersed gas pockets within the viscous gastrointestinal contents to coalesce into larger, free bubbles. The resulting physiological effect is that this consolidated gas supports its easier expulsion via natural physiological processes.

Dosage and Administration Information

Official Administration Guidelines for Mylanta

Administration of Mylanta products, which typically contain a combination of antacids (such as aluminum hydroxide, magnesium hydroxide, and/or calcium carbonate) and simethicone, must strictly follow the instructions provided in the official labeling. The approved route of administration for all formulations is Oral.


Dosage and Frequency

Age Group Dose (Liquid Suspension)* Maximum Daily Dose (24 Hours)
Adults & Children ge 12 Years 10 mL to 20 mL 60 mL (6 doses)
Children < 12 Years Ask a doctor Ask a doctor

The medicine is taken as needed for symptom management, which may be between meals, at bedtime, or as directed by a healthcare provider. For chewable tablets, the typical adult dose is 1 tablet when symptoms occur, not to exceed the product's specified maximum daily limit (e.g., 6 tablets).


Preparation and Duration Constraints

For the liquid suspension, the official instructions mandate that the bottle must be shaken well before each use, and the dose should be measured using the provided dosing cup. Chewable tablets must be chewed thoroughly before swallowing. Mylanta is intended for short-term use; do not use the maximum daily dosage for more than two weeks unless specifically advised by a physician.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Mylanta


Evidence for Immediate Heartburn and Acid Indigestion Relief

Research exploring the use of antacids, like the combination found in Mylanta, has historically focused on measurements related to the ingredients' acid-buffering characteristics. These studies monitored outcomes related to physical discomfort and were applied in research contexts involving fluctuating or episodic symptom patterns of acid indigestion and heartburn. The main research approach has involved Randomized Controlled Trials (RCTs) where adults experiencing acute changes in their symptoms was observed in comparison to a placebo or other treatments. Studies also use laboratory and in vitro assessments to verify the product's ability to buffer stomach acid.

Findings describe patterns observed in the studies, where measurements related to the resulting change in stomach pH levels were reported following administration of the product. Research highlights changes measured during the study period concerning patient-reported outcomes describing perceived discomfort, with some observations reporting initial changes in symptom intensity. However, these findings describe group patterns, not personal outcomes, and they focus primarily on the research exploring short-term symptom changes in conditions involving periods of heightened symptoms.


Evidence for Gas and Bloating Symptoms

The research base also was evaluated in the context of associated outcomes related to systemic or functional imbalance, particularly the gas symptoms often accompanying acid indigestion. RCTs was studied for the simethicone component to see if it was associated with a change in outcomes related to bloating and pressure. Studies explored the association between the simethicone component and conditions associated with acute or disruptive episodes of gas accumulation. Research describes that data show patterns related to the use of simethicone that was observed in some studies to be associated with patient-reported outcomes for gas-related abdominal discomfort. Evidence contributes to understanding symptom patterns by focusing on acute episodes.


Long-Term Study Focus and Follow-Up Duration

The research available data show patterns related to short-term changes in patient-reported outcomes. Follow-up durations were limited across the research for this class of medicine, meaning most observations stop after only a few hours or, at most, one to two weeks of research exploring short-term symptom changes. There is limited information for long-term outcomes regarding sustained use. The long-term effects are not fully established or characterized because most trials are not designed to monitor what happens after continuous use over many months.

Key Studies & References

  1. DailyMed - Mylanta Supreme (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) Suspension Official Label
  2. MedlinePlus Drug Information: Antacids (Oral Route)

Frequently Asked Questions (FAQ)

Common questions about Mylanta (FAQ)

Q: How quickly does Mylanta start working for heartburn?

A: Official documentation describes the action of the active antacid ingredients as direct chemical neutralization of stomach acid. This mechanism is generally associated with rapid onset of action for symptom relief.

Q: Is Mylanta a treatment for occasional heartburn or a long-term therapy?

A: Mylanta is indicated for occasional use for the relief of symptoms. The official warning states that the maximum daily dosage should not be used for more than two weeks, except when advised by a physician.

Q: What types of symptoms is Mylanta typically used to relieve?

A: Official labeling states the product is generally used for the relief of common symptoms such as heartburn, acid indigestion, and sour stomach. Products containing simethicone also address pressure and bloating due to gas.

Q: Is it common to experience side effects like diarrhea with Mylanta?

A: Regulatory documents indicate that diarrhea is a reported side effect associated with the use of this product. This is consistent with the known effects of the magnesium component present in the antacid formulation.

Q: Is constipation a possible side effect of taking Mylanta?

A: Constipation is a reported side effect according to official documents. This is consistent with the known effects of the aluminum component present in the antacid formulation.

Q: Are there any specific medical conditions that may prevent someone from using Mylanta?

A: Official documents advise consulting a healthcare professional before use if a person has certain pre-existing conditions. These conditions may include kidney disease or being on a magnesium-restricted diet, as the product contains both aluminum and magnesium.

Q: Can individuals with kidney problems safely use Mylanta?

A: Official labeling advises consulting a physician before use if a person has kidney disease. This is a crucial safety precaution due to the potential for the build-up of aluminum and magnesium in the body when kidney function is reduced.

Q: What is the general information about using Mylanta while pregnant or breastfeeding?

A: Official information advises consulting a physician if the person is pregnant or breastfeeding before using the product.

Q: Can Mylanta interfere with the absorption of other prescription medications?

A: Yes, antacids may interfere with the body's absorption of certain other oral medications. This is why official labeling contains a drug interaction precaution and advises consulting a physician or pharmacist if presently taking a prescription drug.

Q: Does Mylanta interact with commonly used antibiotics?

A: Official drug interaction information indicates that antacids containing aluminum and magnesium may interact with certain antibiotics, such as tetracyclines and fluoroquinolones, by potentially interfering with their absorption.

Q: How should the use of Mylanta be spaced out when taking thyroid medication?

A: Regulatory-sourced information indicates that antacids may interfere with the absorption of thyroid hormones, such as levothyroxine. If taking these drugs, official precautions advise consulting a physician or pharmacist about appropriate timing and separation of doses.

Q: Are there any age restrictions or warnings for children taking Mylanta?

A: Official directions for use specify a dosage only for adults and children 12 years and over. For children under 12 years of age, the instruction is to consult a physician.

Q: What are the differences between Mylanta and an acid reducer?

A: Mylanta's antacid ingredients (salts of aluminum and magnesium) work by directly neutralizing existing stomach acid. In contrast, acid reducers (like H2 blockers or PPIs) work by reducing or blocking the stomach’s ability to produce acid.

Q: Do all Mylanta products offer anti-gas relief?

A: The official active ingredient list for the standard Mylanta formulations includes the anti-gas agent simethicone. Different Mylanta products or varieties may contain varying active ingredients, and not all may include this component.

Q: Are there different strengths or varieties of Mylanta available?

A: Yes, official product information indicates that Mylanta has been marketed in different formulations, including varieties designated as 'Maximum Strength'. These varieties contain differing concentrations of the active ingredients.

Q: Can Mylanta be used to relieve symptoms associated with a stomach ulcer or gastritis?

A: The ingredients in Mylanta are indicated for general acid-related symptoms. Because of their acid-neutralizing action, these ingredients have been historically described in relation to relieving symptoms in patients with conditions such as a peptic ulcer or gastritis.

Q: Is there a risk of having too much aluminum or magnesium in the body from using Mylanta?

A: Regulatory information indicates a risk of aluminum and/or magnesium accumulation, especially in individuals with kidney problems who use the product. This is why the product is intended for short-term use and not for long-term therapy.

Q: Are there any known food or drink interactions with Mylanta, such as with citrate?

A: Official warnings document that combining aluminum-containing products with citrate (found in many fruit juices and supplements) is a documented interaction. This combination may significantly increase the absorption of aluminum, especially in people with reduced kidney function.

Q: What evidence is there supporting Mylanta's effectiveness for acid indigestion?

A: Mylanta is classified as an Over-the-Counter (OTC) Monograph Drug. This classification means its general recognition as safe and effective for its listed indications (heartburn, acid indigestion) is established and supported by evidence reviewed by regulatory bodies.

Q: Is Mylanta a product that contains sugar or is it typically sugar-free?

A: The official inactive ingredients list for certain Mylanta formulations shows the product is typically formulated with non-sugar sweeteners. Many varieties are marketed as being sugar-free.

Q: What should a person do if they notice signs of an allergic reaction after taking Mylanta?

A: Official warnings state that signs of an allergic reaction (e.g., hives, swelling of the face/throat, difficulty breathing) require stopping use immediately and seeking professional medical help.

Q: Is a metallic taste in the mouth reported as a side effect of antacids like Mylanta?

A: Adverse event data for antacid compounds has occasionally reported a change in taste (dysgeusia). This may include a metallic or unpleasant aftertaste.

Q: Can Mylanta be taken if a person is on a magnesium-restricted diet?

A: Official labeling advises a person to consult a physician before using the product if they are on a magnesium-restricted diet. This is due to the presence of magnesium hydroxide, an active ingredient, in the formulation.

Q: Why is long-term, continuous use of antacids like Mylanta generally discouraged?

A: Long-term, continuous use of the maximum dosage is generally limited to two weeks. This caution is in place due to the potential for systemic risks, including possible electrolyte imbalances and the accumulation of aluminum or magnesium in the body.

Q: Can Mylanta be used for relief from symptoms caused by overindulgence in food or drink?

A: Yes, official labeling specifically includes relief from upset stomach due to overindulgence in food and drink as one of its stated uses, in addition to relief from heartburn and acid indigestion.

Q: What kind of studies have been performed on the main ingredients in Mylanta?

A: The safety and efficacy of the active ingredients (aluminum hydroxide, magnesium hydroxide, simethicone) are supported by clinical and non-clinical studies. These studies form the scientific basis for the product's classification under the OTC Drug Monograph system.

Q: Does Mylanta help with bloating as well as sour stomach?

A: Yes, official labeling lists both sour stomach (related to acid) and pressure and bloating (related to gas) as symptoms the product is used to relieve. The presence of simethicone specifically targets the gas-related symptoms.

Q: Is there a risk of nutrient deficiency, such as phosphate, from prolonged antacid use?

A: Official warnings implicitly caution against prolonged use due to potential systemic effects. Antacids containing aluminum, when used over extended periods, are linked to a risk of hypophosphatemia (low phosphate levels) and associated complications.

Q: Why might a doctor suggest avoiding Mylanta if a patient is taking certain heart medications?

A: Interaction warnings for the antacid components indicate they may interfere with the absorption of certain heart medications, such as digoxin. This interference may potentially reduce the effectiveness of the heart medication.

Q: Are there different Mylanta products marketed for 'maximum strength'?

A: Yes, regulatory listings show that different products have been marketed with names that include terms like 'Maximum Strength'. These varieties contain a higher concentration of the active ingredients than the standard formulation.

Q: Is it possible to take Mylanta only as symptoms occur, or does it require regular use?

A: The official directions state that the medicine is to be taken 'as needed' for the relief of symptoms. It is not intended for a regular daily schedule, but should be used within the specified maximum daily dose and duration.

Q: Does the mechanism of action for the liquid form differ from the chewable tablets?

A: The mechanism of action (direct acid neutralization and anti-gas action) is determined by the active ingredients, not the physical form. Both the liquid suspension and the chewable tablet formulations contain the same types of active ingredients and work similarly.

Q: Is there guidance on what to do if the constipation from Mylanta becomes severe?

A: Official warnings regarding severe adverse effects generally instruct individuals to stop use immediately and seek professional medical attention if they experience severe symptoms or a noticeable worsening of their condition.

Q: Does Mylanta have any effect on general stomach upset not caused by acid?

A: Official indications include the relief of upset stomach generally associated with conditions like heartburn, acid indigestion, or overindulgence. This suggests it targets symptoms related to these acid or gas conditions, rather than general, non-acid-related nausea or illness.

Q: Are there official statements regarding the use of expired Mylanta products?

A: Official guidance for OTC products advises that the safety and effectiveness of the medicine cannot be guaranteed past the expiration date printed on the packaging. The product should be used and stored as directed to maintain its stability until the expiration date.

Q: Why is it recommended to separate the timing of Mylanta from certain other oral drugs?

A: The separation of dosing is generally recommended because the antacid ingredients can interfere with the body’s absorption of certain other oral medications. Taking them too close together may reduce the overall effectiveness of the other drug.

How should Mylanta be stored and disposed of?

Storage and Disposal of Mylanta

Official regulatory labeling dictates specific conditions for storing Mylanta (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone).

Storage Conditions The product must be stored at controlled room temperature, maintaining a range between 20 C to 25 C (68 F to 77 F). It is strictly required that the medicine be kept from freezing and protected from excessive heat to maintain its stability. A mandatory child-safety measure is to keep out of reach of children at all times.

Disposal Instructions Unused or expired product must be disposed of according to local regulations. Consumers are generally advised against flushing this medication down the toilet or pouring it down the drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mylanta found in:

A-Z Index: